Skip to main content
SpringerLink
Log in

Menopausal estrogen use and the risk of breast cancer

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The relationship between the occurrence of female breast cancer and menopausal estrogen replacement was investigated in a population-based case-control study. One hundred and eighty-three white female residents of King County, Washington (ages 50–74) in whom breast cancer was diagnosed from July, 1977, through August, 1978, were interviewed with respect to reproductive and other factors, with emphasis on the use of estrogen-containing medication. For purposes of comparison, the same data were collected from 531 white female King County residents of the same ages without breast cancer. Use of menopausal estrogens was reported somewhat more commonly among controls than among cases (relative risk = 0.74, 95% confidence interval = 0.51−1.08) and some variation in proportions of users was present between different hysterectomy-oophorectomy subgroups. However, each of these differences could easily have been due to chance. No substantial trends in risk were apparent with increasing duration of use, time since first use, time since last use, or average dose. The findings suggest that in King County no important relationship exists between use of menopausal estrogens and the occurrence of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Thomas DB: Non-contraceptive exogenous estrogens and risk of breast cancer: A review. Breast Cancer Res Treat 2: 203–211, 1982

    PubMed  Google Scholar 

  2. Weiss NS, Szekely DR, English DR, Schweid AI: Endo-metrial cancer in relation to patterns of menopausal estrogen use. JAMA 242: 261–264, 1979

    PubMed  Google Scholar 

  3. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719–748, 1959

    PubMed  Google Scholar 

  4. Miettinen O: Estimability and estimation in case-referent studies. Am J Epidemiol 103: 226–235, 1976

    PubMed  Google Scholar 

  5. Mantel N: Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58: 690–700, 1963

    Google Scholar 

  6. Feinleib M: Breast cancer and artifical menopause: a cohort study. J Natl Cancer Inst 41: 315–329, 1968

    PubMed  Google Scholar 

  7. Trichopoulos D, MacMahon B, Cole P: Menopause and breast cancer risk. J Natl Cancer Inst 48: 605–613, 1972

    PubMed  Google Scholar 

  8. Brinton LA, Hoover RN, Szklo M, Fraumeni JF Jr: Menopausal estrogen use and risk of breast cancer. Cancer 47: 2517–2522, 1981

    PubMed  Google Scholar 

  9. Hoover R, Glass A, Finkle WD, Azevedo D, and Milne K: Conjugated estrogens and breast cancer in women. J Natl Cancer Inst 67: 815–820, 1981

    PubMed  Google Scholar 

  10. Hoover R, Gray LA, Cole P, MacMahon B: Menopausal estrogens and breast cancer. New Engl J Med 295: 401–405, 1976

    PubMed  Google Scholar 

  11. Breslow N: Design and analysis of case-control studies. Technical Report No. 47, Department of Biostatistics, School of Public Health and Community Medicine, 1981

  12. Schlesselman JJ: Sample size requirements in cohort and case control studies of disease. Am J Epidemiol 99: 381–384, 1974

    PubMed  Google Scholar 

  13. Boston Collaborative Drug Surveillance Programme: Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. New Engl J Med 290: 15–19, 1974

    Google Scholar 

  14. Burch JC, Byrd BE, Vaughn WK: The effect of long-term estrogen on hysterectomized women. Am J Obstet Gynecol 118: 778–782, 1974

    PubMed  Google Scholar 

  15. Casagrande J, Gerkins V, Henderson BE, Mack T, Pike MC: Exogenous estrogens and breast cancer in women with natural menopause. J Natl Cancer Inst 56: 839–841, 1976

    PubMed  Google Scholar 

  16. Craig MJ, Comstock GW, Geiser PB: Epidemiologic comparison of breast cancer patients with early and late onset of malignancy and general population controls. J Natl Cancer Inst 53: 1577–1581, 1974

    PubMed  Google Scholar 

  17. Henderson BE, Powell D, Rosario I, Keys C, Hanish R, Young M, Casagrande J, Gerkins V, Pike MC: An epidemiologic study of breast cancer. J Natl Cancer Inst 53: 609–614, 1974

    PubMed  Google Scholar 

  18. Hulka BS, Chambless LE, Duebner DC, Wilkinson WE: Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol 143: 638–644, 1982

    PubMed  Google Scholar 

  19. Kaufman DW, Miller DR, Rosenberg L, Helmrich SP, Stolley P, Shottenfeld D, Shapiro S: Noncontraceptive estrogen use and the risk of breast cancer. JAMA 252: 63–67, 1984

    PubMed  Google Scholar 

  20. Mack TM, Henderson BE, Gerkins VR, Arthur M, Baptista J, Pike MC: Reserpine and breast cancer in a retirement community. New Engl J Med 29: 1366–1371, 1975

    Google Scholar 

  21. Ravnihar B, Seigel DG, Lindtner J: An epidemiologic study of breast cancer and benign breast neoplasias in relation to the oral contraceptive and estrogen use. Eur J Cancer 15: 395–405, 1979

    PubMed  Google Scholar 

  22. Sartwell PE, Arthes FG, Tonascia JA: Exogenous hormones, reproductive history and breast cancer. J Natl Cancer Inst 59: 1589–1592, 1977

    PubMed  Google Scholar 

  23. Wynder EL, MacCornack FA, Stellman SD: The epidemiology of breast cancer in 785 United States caucasian women. Cancer 41: 2341–2354, 1978

    PubMed  Google Scholar 

  24. Kelsey JL, Fischer DB, Holford TR, LiVolsi VA, Mostow ED, Goldenberg IS, White C: Exogenous estrogens and other factors in the epidemiology of breast cancer. J Natl Cancer Inst 67: 327–333, 1981

    PubMed  Google Scholar 

  25. Ross RK, Paganini-Hill A, Gerkins VR, Mack TM, Pfeffer R, Arthur M, Henderson BE: A case-control study of menopausal estrogen therapy and breast cancer. JAMA 243: 1635–1639, 1980

    PubMed  Google Scholar 

  26. Jick H, Walker AM, Watkins RN, D'Ewart DC, Hunter JR, Danford A, Madsen S, Dinan BJ, Rothman KJ: Re-placement estrogens and breast cancer. Am J Epidemiol 112: 586–594, 1980

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology SC-36, School of Public Health and Community Medicine, University of Washington, 98195, Seattle, Washington, USA

    Jill A. McDonald, Noel S. Weiss & Janet R. Daling

  2. The Division of Public Health Sciences, The Fred Hutchinson Cancer Research Center, 1124 Columbia Street, 98104, Seattle, Washington, USA

    Noel S. Weiss, Janet R. Daling, Anita M. Francis & Lincoln Polissar

Authors
  1. Jill A. McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noel S. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Janet R. Daling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anita M. Francis
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lincoln Polissar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McDonald, J.A., Weiss, N.S., Daling, J.R. et al. Menopausal estrogen use and the risk of breast cancer. Breast Cancer Res Tr 7, 193–199 (1986). https://doi.org/10.1007/BF01806250

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806250

Keywords

Search

Navigation